Robotics, automation, active electrode arrays, and new devices for cochlear implantation: A contemporary review

D De Seta, H Daoudi, R Torres, E Ferrary, O Sterkers… - Hearing Research, 2022 - Elsevier
In the last two decades, cochlear implant surgery has evolved into a minimally invasive,
hearing preservation surgical technique. The devices used during surgery have benefited …

[HTML][HTML] Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss

K Xu, B Xu, J Gu, X Wang, D Yu, Y Chen - Theranostics, 2023 - ncbi.nlm.nih.gov
Noise accounts for one-third of hearing loss worldwide. Regretfully, noise-induced hearing
loss (NIHL) is deemed to be irreversible due to the elusive pathogenic mechanisms that …

Blood–Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients

A Cosentino, A Agafonova, S Modafferi… - Antioxidants & Redox …, 2024 - liebertpub.com
Significance: The stria vascularis, located in the inner ear, consists of three layers, one of
which is the blood–labyrinth barrier (BLB). It is formed by endothelial cells, sealed together …

Nanocarriers for drug delivery to the inner ear: Physicochemical key parameters, biodistribution, safety and efficacy

C Jaudoin, F Agnely, Y Nguyen, E Ferrary… - International Journal of …, 2021 - Elsevier
Despite the high incidence of inner ear disorders, there are still no dedicated medications on
the market. Drugs are currently administered by the intratympanic route, the safest way to …

Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise

G Naert, MP Pasdelou, CG Le Prell - The Journal of the Acoustical …, 2019 - pubs.aip.org
Stebbins et al.(1982) suggested the guinea pig to be one of the most useful species in which
to assess the effects of noise on the inner ear based on overlap with the audible frequency …

Steroid nomenclature in inner ear therapy

AN Salt, SK Plontke - Otology & Neurotology, 2020 - journals.lww.com
Abstract Local glucocorticosteroid (“steroid”) therapy is widely used to treat the inner ears of
patients with Menière's disease, idiopathic sudden sensorineural hearing loss and in …

[HTML][HTML] Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide-co-glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating …

JA Cho, BJ Kim, YJ Hwang, SW Woo, TS Noh… - International Journal of …, 2021 - mdpi.com
The treatment of acute hearing loss is clinically challenging due to the low efficacy of drug
delivery into the inner ear. Local intratympanic administration of dexamethasone (D) and …

[HTML][HTML] Advances and challenges in pharmaceutical therapies to prevent and repair cochlear injuries from noise

EC Bielefeld, MJ Kobel - Frontiers in Cellular Neuroscience, 2019 - frontiersin.org
Noise induces a broad spectrum of pathological injuries to the cochlea, reflecting both
mechanical damage to the delicate architecture of the structures of the organ of Corti and …

[HTML][HTML] Dual viscosity mixture vehicle for intratympanic dexamethasone delivery can block ototoxic hearing loss

H Li, MW Suh, SH Oh - Frontiers in Pharmacology, 2021 - frontiersin.org
Clinically there is no effective method to prevent drug induced hearing loss in patients
undergoing chemotherapy and anti-tuberculosis therapy. In this study, we developed an …

[HTML][HTML] High-molecular-weight hyaluronic acid vehicle can deliver gadolinium into the cochlea at a higher concentration for a longer duration: a 9.4-T magnetic …

YJ Hwang, M Park, MK Park, JH Lee, SH Oh… - Frontiers in …, 2021 - frontiersin.org
Intratympanic (IT) gadolinium (Gd) injection is one method of delivering Gd into the inner ear
to evaluate the amount of endolymphatic hydrops (EH) using magnetic resonance imaging …